<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/12267" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/12267</id>
  <updated>2026-04-09T05:13:18Z</updated>
  <dc:date>2026-04-09T05:13:18Z</dc:date>
  <entry>
    <title>A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/12287" />
    <author>
      <name>Alwafi, Hassan</name>
    </author>
    <author>
      <name>Alsulaimani, Nedaa</name>
    </author>
    <author>
      <name>Almalki, Mohammed E.</name>
    </author>
    <author>
      <name>Mohammad Banjar, Asma</name>
    </author>
    <author>
      <name>Abdullah Alamri, Reham</name>
    </author>
    <author>
      <name>Alwafi, Danya</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/12287</id>
    <updated>2025-07-22T02:25:30Z</updated>
    <published>2025-03-01T00:00:00Z</published>
    <summary type="text">Title: A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia
Authors: Alwafi, Hassan; Alsulaimani, Nedaa; Almalki, Mohammed E.; Mohammad Banjar, Asma; Abdullah Alamri, Reham; Alwafi, Danya
Abstract: Abstract&#xD;
Since the COVID-19 vaccines have been approved, worldwide reports of adverse events have been reported.&#xD;
Although a few cases of Psoriasis vulgaris have been reported after COVID-10 vaccination, there is currently&#xD;
limited evidence to establish a direct relationship between the vaccine and this condition. A 27-year-old Saudi&#xD;
woman, previously healthy and had no medical issues, reported skin lesions on her lower legs, which she&#xD;
noticed ten (10) days after receiving the first dose of the Pfizer COVID-19 vaccine. The patient had no prior&#xD;
history of such lesions or any family history of psoriasis. Joint pain was not observed. A diagnosis of psoriasis&#xD;
vulgaris was made, and the patient was treated with Daivobet® cream, urea cream 10%, and full-body NB-UVB&#xD;
light therapy three times a week for up to two months. The patient's condition improved partially. This report&#xD;
presents the first known case of psoriasis vulgaris after the COVID-19 vaccine in the Middle East. Further&#xD;
research is needed to fully understand this connection. The study emphasizes the significance of a thorough&#xD;
medical history and evaluation for precise diagnosis and treatment.&#xD;
Keywords: COVID-19, drug-related side effects and adverse reactions, SARS-CoV-2, vaccines, vulgaris</summary>
    <dc:date>2025-03-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Success Rate and Complications of Percutaneous Nephrolithotomy (PCNL) in Nephrolithiasis Patients</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/12286" />
    <author>
      <name>Kevin Stein, Lambok</name>
    </author>
    <author>
      <name>Safriadi, Ferry</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/12286</id>
    <updated>2025-07-22T02:22:14Z</updated>
    <published>2025-03-01T00:00:00Z</published>
    <summary type="text">Title: Success Rate and Complications of Percutaneous Nephrolithotomy (PCNL) in Nephrolithiasis Patients
Authors: Kevin Stein, Lambok; Safriadi, Ferry
Abstract: Abstract&#xD;
Percutaneous Nephrolithotomy (PCNL) is the standard management method for kidney stones due to its high&#xD;
success rates. This process is associated with risks, including complications such as infection and bleeding.&#xD;
This study aimed to evaluate the complications and success rates of PCNL in nephrolithiasis patients and&#xD;
provide important insights for clinical decision-making. Data were collected from patients undergoing PCNL&#xD;
for nephrolithiasis at Dr. Hasan Sadikin General Hospital Bandung, Indonesia, in the form of demographic&#xD;
data, stone parameters, and postoperative complications. Data were then analyzed statistically to identify&#xD;
the associated factors. This study was conducted at the Urology Department of the hospital from January&#xD;
to December 2023, involving 80 nephrolithiasis cases. Predominantly, 67.5% of patients were males, with&#xD;
63.7% in the age group of above 50 years. Multiple stones were the most common (55%), with stone sizes&#xD;
of ≥1.5 cm prevalent in 95% of cases. Left-sided stones (43.8%) were most frequent, followed by rightsided (36.2%) and bilateral stones (20%). Hydronephrosis complications were present in 36.2% of cases,&#xD;
with 100% stone clearance found in Guy Stone Score (GSS) grade 1 cases, while GSS grade 4 cases exhibited&#xD;
the lowest stone clearance rate at 45.4%. This study provided insights into nephrolithiasis demographics,&#xD;
stone characteristics, and postoperative outcomes. Male predominance, multiple stones, high rates of stone&#xD;
clearance, and postoperative complications, particularly in the Guy’s score system, underscore the need for&#xD;
proper management strategies and further research in this field.&#xD;
Keywords: Complication, nephrolithiasis, percutaneous nephrolithotomy, success rate</summary>
    <dc:date>2025-03-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Comparison of CONUT Score, SGA Score, and GLIM Score as Gold Standard for Colorectal Cancer Patients</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/12285" />
    <author>
      <name>Marcella, Marcella</name>
    </author>
    <author>
      <name>Rudiman, Reno</name>
    </author>
    <author>
      <name>Yohana, Raden</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/12285</id>
    <updated>2025-07-22T02:20:45Z</updated>
    <published>2025-03-01T00:00:00Z</published>
    <summary type="text">Title: Comparison of CONUT Score, SGA Score, and GLIM Score as Gold Standard for Colorectal Cancer Patients
Authors: Marcella, Marcella; Rudiman, Reno; Yohana, Raden
Abstract: Abstract&#xD;
Malnutrition in colorectal cancer increases toxicity, worsens quality of life, and reduces body functions. Early&#xD;
identification of malnutrition is crucial to determine treatments. This study compared the Global Leadership&#xD;
Initiative on Malnutrition (GLIM) score as the standard nutritional status screening tool to the Controlling&#xD;
Nutritional Status (CONUT) and Subjective Global Assessment (SGA) scores. This study expected to identify&#xD;
a new nutritional status screening tool for colorectal cancer patients. This was a cross-sectional diagnostic&#xD;
study on 60 colorectal cancer patients treated at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from&#xD;
August 16, 2022 to July 16, 2023. Results revealed that the CONUT score had a sensitivity, specificity, accuracy,&#xD;
and effectiveness values of 80.4%, 0.0%, 85%, and 85%, respectively, in detecting malnutrition. The SGA score&#xD;
had a sensitivity value of 100%, a specificity value of 21.95%, an accuracy value of 85%, and an effectiveness of&#xD;
85% in detecting malnutrition. When compared with the GLIM score as the gold standard, which is assumed to&#xD;
have a sensitivity and specificity values of 100%, the SGA score was better than the CONUT score for detecting&#xD;
malnutrition in colorectal cancer patients. The SGA score is closest to the GLIM score as the gold standard for&#xD;
assessing malnutrition in colorectal cancer patients..&#xD;
Keywords: Colorectal cancer, controlling nutritional status, global leadership initiative on malnutrition,&#xD;
 malnutrition, subjective global assessment</summary>
    <dc:date>2025-03-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Neutrophil Lymphocyte Ratio and Mortality in Patients with Acute Limb Ischemia</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/12284" />
    <author>
      <name>Hapsari, Putie</name>
    </author>
    <author>
      <name>Marfen, Teguh</name>
    </author>
    <author>
      <name>Bayu Nugroho, Hendri</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/12284</id>
    <updated>2025-07-22T02:18:58Z</updated>
    <published>2025-03-01T00:00:00Z</published>
    <summary type="text">Title: Neutrophil Lymphocyte Ratio and Mortality in Patients with Acute Limb Ischemia
Authors: Hapsari, Putie; Marfen, Teguh; Bayu Nugroho, Hendri
Abstract: Abstract&#xD;
Acute Limb Ischemia (ALI) is a sudden decrease in limb perfusion with a potential of limb loss and is an&#xD;
indication for immediate vascular intervention. Apart from reducing the quality of life, the mortality rate in&#xD;
ALI is reported to be high, i.e., around 40%. Neutrophil Lymphocyte Ratio (NLR) can be used to reflect the&#xD;
inflammatory process in this condition. This study aimed to assess the correlation of NLR to mortality rate&#xD;
in ALI Rutherford Category III patients treated in Dr. Hasan Sadikin General Hospital Bandung, Indonesia.&#xD;
This was a cross-sectional analytical observative retrospective study on data collected from medical records&#xD;
of ALI Rutherford Category III patients treated in the hospital from 2019 to 2022. Sampling was performed&#xD;
consecutively and data were processed using the SPSS with univariate analysis and bivariate analysis using&#xD;
Kendall's tau b analysis test. Results demonstrated that of a total of 46 patients, the majority were female&#xD;
patients (n=31) and 28 patients died. The mean NLR levels in patients who survived was 5.8, in contrast with&#xD;
9.7 observed among those who died. The statistical test results showed a significant correlation between the&#xD;
NLR and mortality rate of ALI Rutherford category III patients (p&lt;0.05), albeit weak positive correlation (r&#xD;
value=0.35). The higher the NLR value was, the higher the risk of death. Hence, the NLR value could be used to&#xD;
recognize the risk of death among these patients.&#xD;
Keywords: Acute limb ischemia (ALI), NLR, mortality rate</summary>
    <dc:date>2025-03-01T00:00:00Z</dc:date>
  </entry>
</feed>

